BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20965497)

  • 1. Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.
    Castner SA; Smagin GN; Piser TM; Wang Y; Smith JS; Christian EP; Mrzljak L; Williams GV
    Biol Psychiatry; 2011 Jan; 69(1):12-8. PubMed ID: 20965497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease.
    Bitner RS; Bunnelle WH; Decker MW; Drescher KU; Kohlhaas KL; Markosyan S; Marsh KC; Nikkel AL; Browman K; Radek R; Anderson DJ; Buccafusco J; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):875-86. PubMed ID: 20504913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates.
    Bontempi B; Whelan KT; Risbrough VB; Rao TS; Buccafusco JJ; Lloyd GK; Menzaghi F
    J Pharmacol Exp Ther; 2001 Oct; 299(1):297-306. PubMed ID: 11561092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (R)-3'-(3-methylbenzo[b]thiophen-5-yl)spiro[1-azabicyclo[2,2,2]octane-3,5'-oxazolidin]-2'-one, a novel and potent alpha7 nicotinic acetylcholine receptor partial agonist displays cognitive enhancing properties.
    Tatsumi R; Fujio M; Takanashi S; Numata A; Katayama J; Satoh H; Shiigi Y; Maeda J; Kuriyama M; Horikawa T; Murozono T; Hashimoto K; Tanaka H
    J Med Chem; 2006 Jul; 49(14):4374-83. PubMed ID: 16821797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
    Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
    Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys.
    Buccafusco JJ; Terry AV; Decker MW; Gopalakrishnan M
    Biochem Pharmacol; 2007 Oct; 74(8):1202-11. PubMed ID: 17706609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats: a pharmacokinetic and behavioral study.
    van Goethem NP; Prickaerts J; Welty D; Flood DG; Koenig G
    Behav Pharmacol; 2015 Jun; 26(4):403-6. PubMed ID: 25794332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of R3487/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats.
    Rezvani AH; Kholdebarin E; Brucato FH; Callahan PM; Lowe DA; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):269-75. PubMed ID: 19110025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective alpha7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes.
    Sydserff S; Sutton EJ; Song D; Quirk MC; Maciag C; Li C; Jonak G; Gurley D; Gordon JC; Christian EP; Doherty JJ; Hudzik T; Johnson E; Mrzljak L; Piser T; Smagin GN; Wang Y; Widzowski D; Smith JS
    Biochem Pharmacol; 2009 Oct; 78(7):880-8. PubMed ID: 19615981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys.
    Ramos BP; Colgan L; Nou E; Ovadia S; Wilson SR; Arnsten AF
    Biol Psychiatry; 2005 Dec; 58(11):894-900. PubMed ID: 16043136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic receptors in the habenula: importance for memory.
    Sanders D; Simkiss D; Braddy D; Baccus S; Morton T; Cannady R; Weaver N; Rose JE; Levin ED
    Neuroscience; 2010 Mar; 166(2):386-90. PubMed ID: 20034548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
    Ye JW; Cai JX; Wang LM; Tang XC
    J Pharmacol Exp Ther; 1999 Feb; 288(2):814-9. PubMed ID: 9918593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
    Schneider JS; Tinker JP; Van Velson M; Menzaghi F; Lloyd GK
    J Pharmacol Exp Ther; 1999 Aug; 290(2):731-9. PubMed ID: 10411585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory.
    Fernandes C; Hoyle E; Dempster E; Schalkwyk LC; Collier DA
    Genes Brain Behav; 2006 Aug; 5(6):433-40. PubMed ID: 16923147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment.
    Curzon P; Anderson DJ; Nikkel AL; Fox GB; Gopalakrishnan M; Decker MW; Bitner RS
    Neurosci Lett; 2006 Dec; 410(1):15-9. PubMed ID: 17055644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of working, short- and long-term memory by nicotinic receptors in the basolateral amygdala in rats.
    Barros DM; Ramirez MR; Izquierdo I
    Neurobiol Learn Mem; 2005 Mar; 83(2):113-8. PubMed ID: 15721794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
    Terry AV; Buccafusco JJ; Borsini F; Leusch A
    Psychopharmacology (Berl); 2002 Jul; 162(3):292-300. PubMed ID: 12122487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J; Ray R; Wileyto EP; Ruparel K; Sanborn P; Siegel S; Gur RC; Lerman C
    Biol Psychiatry; 2010 Apr; 67(8):715-21. PubMed ID: 20207347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinic receptor subtypes and cognitive function.
    Levin ED
    J Neurobiol; 2002 Dec; 53(4):633-40. PubMed ID: 12436426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.